ATLX Q4 2025 Earnings NarrowerThanExpected Loss Fails to Lift Shares TOI Q1 2026 Earnings Strong Earnings Beat Amidst Limited Revenue Disclosure Dyne Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Drives Slight Stock Uptick Imperial Oil Q1 2026 Earnings Earnings Miss Amid Weaker Upstream Margins Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD